Brief: NextCure Publishes Non-Clinical Data Defining The Mechanism Of Action For NC525, A Novel LAIR-1 Antibody For AML

NextCure

15/11/2023 22:03

Nov 15 (Reuters) - NextCure Inc  NXTC.O :
    * NEXTCURE PUBLISHES NON-CLINICAL DATA DEFINING THE
MECHANISM OF
ACTION FOR NC525, A NOVEL LAIR-1 ANTIBODY FOR AML
    * NEXTCURE INC - UPDATE FOR ONGOING PHASE 1A CLINICAL TRIAL
IS
EXPECTED IN Q4 OF 2023

Source text for Eikon:  ID:nGNX8lzqcm 
Further company coverage:  NXTC.O 

 ((reuters.briefs@thomsonreuters.com;))